Synaptic plasticity and addiction
Top Cited Papers
- 1 November 2007
- journal article
- review article
- Published by Springer Nature in Nature Reviews Neuroscience
- Vol. 8 (11) , 844-858
- https://doi.org/10.1038/nrn2234
Abstract
Addiction is caused, in part, by powerful and long-lasting memories of the drug experience. Relapse caused by exposure to cues associated with the drug experience is a major clinical problem that contributes to the persistence of addiction. Here we present the accumulated evidence that drugs of abuse can hijack synaptic plasticity mechanisms in key brain circuits, most importantly in the mesolimbic dopamine system, which is central to reward processing in the brain. Reversing or preventing these drug-induced synaptic modifications may prove beneficial in the treatment of one of society's most intractable health problems.Keywords
This publication has 142 references indexed in Scilit:
- Endocannabinoid-Mediated Long-Term Plasticity Requires cAMP/PKA Signaling and RIM1αNeuron, 2007
- Glutamate synaptic inputs to ventral tegmental area neurons in the rat derive primarily from subcortical sourcesNeuroscience, 2007
- Hypocrétines : entre l’envie et le besoin… ou l’émergence d’une nouvelle voie d’origine hypothalamique impliquée dans la motivation et l’addictionmédecine/sciences, 2006
- BDNF-dependent synaptic sensitization in midbrain dopamine neurons after cocaine withdrawalNature Neuroscience, 2006
- Synaptic basis for developmental plasticity in somatosensory cortexCurrent Opinion in Neurobiology, 2004
- Glutamate-associated plasticity in the ventral tegmental area is necessary for conditioning environmental stimuli with morphineNeuroscience, 2004
- LTP in the mouse nucleus accumbens is developmentally regulatedSynapse, 2002
- RIM1α is required for presynaptic long-term potentiationNature, 2002
- Chronic administration of (+)-amphetamine alters the reactivity of midbrain dopaminergic neurons to prefrontal cortex stimulation in the ratBrain Research, 1995
- Blockade of “reverse tolerance” to cocaine and amphetamine by MK-801Life Sciences, 1989